Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), bought 44,158 shares at $60.52 ($2.7M) on 2018-02-27, disclosed to the SEC on 2018-02-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.52 | 100 | $6K | 0.2% |
| 2 | $60.53 | 100 | $6K | 0.2% |
| 3 | $60.56 | 500 | $30K | 1.1% |
| 4 | $60.57 | 400 | $24K | 0.9% |
| 5 | $60.58 | 100 | $6K | 0.2% |
| 6 | $60.58 | 100 |
| $6K |
| 0.2% |
| 7 | $60.59 | 600 | $36K | 1.4% |
| 8 | $60.59 | 100 | $6K | 0.2% |
| 9 | $60.60 | 100 | $6K | 0.2% |
| 10 | $60.60 | 700 | $42K | 1.6% |
| 11 | $60.60 | 14 | $848 | 0.0% |
| 12 | $60.61 | 14 | $849 | 0.0% |
| 13 | $60.61 | 600 | $36K | 1.4% |
| 14 | $60.62 | 1,417 | $86K | 3.2% |
| 15 | $60.63 | 700 | $42K | 1.6% |
| 16 | $60.63 | 200 | $12K | 0.5% |
| 17 | $60.64 | 1,300 | $79K | 2.9% |
| 18 | $60.64 | 200 | $12K | 0.5% |
| 19 | $60.65 | 1,500 | $91K | 3.4% |
| 20 | $60.65 | 1,600 | $97K | 3.6% |
| 21 | $60.66 | 1,600 | $97K | 3.6% |
| 22 | $60.66 | 600 | $36K | 1.4% |
| 23 | $60.67 | 2,799 | $170K | 6.3% |
| 24 | $60.67 | 600 | $36K | 1.4% |
| 25 | $60.67 | 103 | $6K | 0.2% |
| 26 | $60.68 | 103 | $6K | 0.2% |
| 27 | $60.68 | 4,500 | $273K | 10.2% |
| 28 | $60.69 | 487 | $30K | 1.1% |
| 29 | $60.69 | 4,400 | $267K | 10.0% |
| 30 | $60.69 | 487 | $30K | 1.1% |
| 31 | $60.70 | 500 | $30K | 1.1% |
| 32 | $60.70 | 4,800 | $291K | 10.9% |
| 33 | $60.70 | 500 | $30K | 1.1% |
| 34 | $60.70 | 700 | $42K | 1.6% |
| 35 | $60.71 | 700 | $42K | 1.6% |
| 36 | $60.71 | 100 | $6K | 0.2% |
| 37 | $60.71 | 8,100 | $492K | 18.4% |
| 38 | $60.71 | 100 | $6K | 0.2% |
| 39 | $60.72 | 1,317 | $80K | 3.0% |
| 40 | $60.72 | 1,317 | $80K | 3.0% |
| Total | $60.68 avg | 44,158 | $2.7M | 100% |
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |